European research labs led by Belgium-based imec will receive €2.5B in funding under European Chips Act to set up a pilot line to develop and test sub-2nm chips
Context & Ripple Effects
The award turns the Chips Act from a broad funding ambition into a named R&D facility centered on imec. It follows the Commission's earlier approval of €8B in chip-research subsidies, alongside private funding, under the same policy framework.
The pilot line is also positioned to connect advanced-node research with the manufacturing tooling ecosystem: ASML and imec soon opened a High-NA EUV test laboratory intended to support customer production preparation.
First-order effects
- Imec-led European labs gain €2.5B to build a shared pilot line for developing and testing sub-2nm chips, expanding their ability to validate processes before commercial fabrication.
- European chip-tool, materials and design partners can use a regional research platform rather than relying solely on external development routes for leading-edge process work.
Second-order effects
- The facility raises the value of collaboration around imec for equipment suppliers such as ASML and for prospective chip customers, because process learning and tool qualification can be coordinated earlier.
- Other regions pursuing advanced-node capability face a more organized European R&D counterpart; the immediate competition is over research access and know-how, not yet equivalent manufacturing capacity.
Third-order effects
- If pilot-line work translates into repeatable processes, Europe could strengthen its position in the upstream research and equipment layers of the semiconductor supply chain even without matching all leading-edge fab investment.
- The move reflects a policy model in which public funding de-risks shared pre-competitive infrastructure; its lasting impact depends on whether research users can carry results into commercial production.
The trend: Governments are increasingly funding shared advanced-chip R&D infrastructure to secure strategic roles in the semiconductor value chain, while commercial-scale capacity remains a separate challenge.